| abstract |
The present invention provides an oxazolidinone derivative compound represented by chemical formula I, an optical isomer thereof, or pharmaceutically acceptable salts thereof. The compound represented by chemical formula I according to the present invention has a CETP-inhibiting effect, which leads to the effects of increasing HDL cholesterol and reducing LDL cholesterol, and a pharmaceutical composition containing the compound can be used for treating or preventing a disorder or a disease which is mediated by CETP or responds to CETP inhibition. |